Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

5. Accounts Receivable

5. Accounts Receivable

12 Months Ended

Mar. 31, 2017

Accounts receivable, net consists of the following:

	March 31,
	2017			2016
Accounts receivable	$	2,794,000		$	2,176,000
Less: allowance for doubtful accounts		(14,000	)		(15,000	)
Less: discounts, rebates, distributor fees and returns		(672,000	)		(653,000	)
	$	2,108,000		$	1,508,000

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details